Press Releases - 2023-12-12

Date	Title	Company
12-Dec-2023	Gene Expression Market Hits $17.96 Billion by 2031 – Explore the Dynamics of Synthesis, Transcription, and Translation Processes with a 7.7% CAGR	The Wire Times
12-Dec-2023	Global Foot and Ankle Devices Industry is poised to achieve a 5.9% CAGR, potentially reaching US$ 7.8 Billion by 2032	MARKITWIRED
12-Dec-2023	Digital Wound Measurement Devices Market from $401M (2020) to Projected $623.01M (2030) at 4.6% CAGR – An In-Depth Analysis of 3D-Enabled Solutions and EMR Integration	The Wire Times
12-Dec-2023	Global Breast Lesion Localization Industry to maintain a 4.1% CAGR till 2032, underscoring the vitality of advancements \| FMI	MARKITWIRED
12-Dec-2023	IRLAB is Granted Additional Patent for Drug Candidate Pirepemat that Expands its Patent Protection	AccessWire
12-Dec-2023	Global Flow Diverters Industry is expected to surge and reach US$ 1.3 Billion by 2032 as per FMI’s analysis	MARKITWIRED
12-Dec-2023	L&T Technology Services and bp Sign Multi-Year Engineering Services Partnership	Businesswire
12-Dec-2023	Global Cardiac Rehabilitation Industry is anticipated to maintain a consistent rise with a 6.0% CAGR from 2022 to 2032 \| FMI	MARKITWIRED
12-Dec-2023	Global Veterinary Orthopedics Industry Set to Surge with a 9.4% CAGR by 2022 to 2032 Projections, Covering a Range of Species from Equines to Canines \| FMI	MARKITWIRED
12-Dec-2023	Cimeio Therapeutics Presents Data for its CD45 Universal Heme ADC at ASH	Businesswire
12-Dec-2023	Two Early Studies Evaluating Potential First-in-Class CELMoD™ Agent Golcadomide for the Treatment of Non-Hodgkin Lymphomas Presented at ASH 2023	Businesswire
12-Dec-2023	Bristol Myers Squibb Announces Data at ASH 2023 from Diverse Multiple Myeloma Pipeline, Underscoring Range of Tailored Treatment Approaches to Address Unique Patient Needs	Businesswire
12-Dec-2023	Abecma Delivers Sustained Progression-Free Survival Versus Standard Regimens in Earlier Lines of Therapy for Relapsed and Refractory Multiple Myeloma Based on Longer-Term Follow-up from KarMMa-3	Businesswire
12-Dec-2023	Positive Results from Pivotal Trials of CASGEVY™ (exagamglogene autotemcel) Highlighted in Oral Presentations at the American Society of Hematology (ASH) Annual Meeting and Exposition	Businesswire
12-Dec-2023	Patient-Reported Outcomes from the CARTITUDE-4 Study Showed Clinically Meaningful Improvements in Health-Related Quality of Life and Reductions in Multiple Myeloma Symptoms Following Treatment with CARVYKTI® (ciltacabtagene autoleucel)	Businesswire
12-Dec-2023	BioCT Names Dr. Stephen Bloch its 2023 Entrepreneur of the Year	Businesswire